Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
3 NC counties are under alert, including Johnston County.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pyxis Oncology Inc
(NQ:
PYXS
)
3.710
+0.060 (+1.64%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pyxis Oncology Inc
< Previous
1
2
3
Next >
PYXS Stock Earnings: Pyxis Oncology Misses EPS for Q2 2024
August 14, 2024
PYXS stock results show that Pyxis Oncology missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024
August 14, 2024
From
Pyxis Oncology
Via
GlobeNewswire
Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference
July 29, 2024
From
Pyxis Oncology
Via
GlobeNewswire
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 28, 2024
From
Pyxis Oncology
Via
GlobeNewswire
Pyxis Oncology: Q4 Earnings Insights
March 21, 2024
Via
Benzinga
Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger
June 10, 2024
From
Pyxis Oncology
Via
GlobeNewswire
Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference
May 30, 2024
From
Pyxis Oncology
Via
GlobeNewswire
PYXS Stock Earnings: Pyxis Oncology Beats EPS, Beats Revenue for Q1 2024
May 14, 2024
PYXS stock results show that Pyxis Oncology beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
May 14, 2024
From
Pyxis Oncology
Via
GlobeNewswire
Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference
May 09, 2024
From
Pyxis Oncology
Via
GlobeNewswire
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 03, 2024
Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Retail Roundup investor conference where the company reportedly...
Via
Benzinga
Exposures
Glyphosate
Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On Wednesday
April 03, 2024
U.S. stocks were higher, with the Dow Jones gaining over 50 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 28, 2024
From
Pyxis Oncology
Via
GlobeNewswire
3 Biotech Stocks to Buy on the Dip: March 2024
March 27, 2024
Some of the best opportunities can be found in dips in some of the top biotech stocks to buy. In fact, here are three.
Via
InvestorPlace
Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights
March 27, 2024
From
Pyxis Oncology
Via
GlobeNewswire
Why FedEx Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
March 22, 2024
Shares of FedEx Corporation (NYSE: FDX) rose sharply in today’s pre-market trading after the company reported better-than-expected earnings for its third quarter and authorized a new $5 billion
Via
Benzinga
PYXS Stock Earnings: Pyxis Oncology Beats EPS for Q4 2023
March 21, 2024
PYXS stock results show that Pyxis Oncology beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023
March 21, 2024
From
Pyxis Oncology
Via
GlobeNewswire
Why FactSet Research Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 21, 2024
Shares of FactSet Research Systems Inc. (NYSE: FDS) fell sharply during Thursday’s session after the company reported worse-than-expected second-quarter revenue and issued FY24 guidance.
Via
Benzinga
From Six Figures to Seven: 3 Biotech Stocks Set to Make Millionaires
March 19, 2024
These biotech stocks to buy offer a gateway to long-term gains, on the back of groundbreaking healthcare innovations.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
March 15, 2024
It's time to start the final day of trading this week with a look into the biggest pre-market stock movers for Friday morning!
Via
InvestorPlace
Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA
March 13, 2024
From
Pyxis Oncology
Via
GlobeNewswire
Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024
March 07, 2024
From
Pyxis Oncology
Via
GlobeNewswire
Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting
March 05, 2024
From
Pyxis Oncology
Via
GlobeNewswire
Pyxis Oncology Announces $50 Million Private Placement
February 27, 2024
From
Pyxis Oncology
Via
GlobeNewswire
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 27, 2024
Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.
Via
Benzinga
3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024
February 22, 2024
With new innovation and high demand, biotech stocks could offer some of the most explosive opportunities of the year.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
December 29, 2023
Via
Benzinga
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 29, 2023
From
Pyxis Oncology
Via
GlobeNewswire
Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer
November 28, 2023
Dr. Kobayashi brings over 25 years of experience in oncology drug development, including Antibody Drug Conjugates (ADCs) and other oncology modalities
From
Pyxis Oncology
Via
GlobeNewswire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.